What drove the decline in net sales during the third quarter of 2023?

The decline in net sales was primarily driven by a 15% decrease in sales volume. This was due to factors such as strategic product exits, crop protection inventory destocking trends, timing of seasonal demand, delayed farmer purchases, lower planted area in Brazil, and an earlier operational finish to the season in North America compared to the prior year.

How did the acquisitions of Stoller and Symborg impact the financial results?

The acquisitions of Stoller and Symborg, completed on March 1, 2023, supplemented Corteva's Crop Protection business with biological tools. While they contributed positively to portfolio and other impacts on net sales, the financial statements indicate incremental costs associated with these acquisitions, particularly in Selling, General, and Administrative (SG&A) expenses and amortization of intangible assets.

What is the outlook for Corteva for the full year 2023?

Corteva affirmed its full-year 2023 outlook, expecting net sales in the range of $17.0 billion to $17.3 billion and Operating EBITDA in the range of $3.25 billion to $3.45 billion. Operating Earnings Per Share is expected to be between $2.50 and $2.70 per share.

What significant charges or restructuring actions were undertaken?

Corteva recorded $2 million in restructuring and asset related charges in Q3 2023, a significant decrease from $152 million in Q3 2022. For the nine months ended September 30, 2023, these charges were $95 million, down from $300 million in the prior year. Additionally, a new plan to optimize the Crop Protection network was announced, expected to result in $410 million to $460 million in pre-tax charges.

CTVA 10-Q Quarterly Report Q3 FY2023 — Revenue, Net Income, EPS

Summary

Corteva, Inc. reported a net sales decline of 7% for the third quarter of 2023 compared to the prior year, driven primarily by a 15% decrease in volume, though partially offset by price increases and favorable currency impacts. For the first nine months of the year, net sales saw a slight decrease of 1%, also primarily due to lower volumes which were impacted by strategic product exits, inventory destocking, and delayed farmer purchases. The company has been investing in research and development, with an increase in R&D expenses year-over-year to support long-term growth. Significant progress has been made integrating the Stoller and Symborg acquisitions, which supplement the crop protection business with biological tools. Despite the sales volume challenges, Corteva's financial performance was supported by pricing strategies and cost management initiatives. The company is also actively managing its capital structure, including share repurchases and dividend payments.

Financial Highlights

53 data points

Beta

Revenue

$2.59B

0.4% Gross Margin

Net Income

-$321.00M

-0.1% Net Margin

EPS (Diluted)

$-0.45

Total Assets

$43.11B

Cash & Equivalents

$2.25B

Free Cash Flow

-$105.00M

Financial Statements

Beta

Revenue	$2.59B
Cost of Revenue	$1.65B
Gross Profit	$944.00M
R&D Expenses	$335.00M
SG&A Expenses	$670.00M
Net Income	-$321.00M
EPS (Basic)	$-0.45
EPS (Diluted)	$-0.45
Shares Outstanding (Basic)	708.40M
Shares Outstanding (Diluted)	708.40M

Key Highlights

1Net sales decreased by 7% in Q3 2023 and 1% year-to-date, primarily due to lower sales volumes.
2Research and Development (R&D) expenses increased by 7% in Q3 and 12% year-to-date, indicating continued investment in innovation.
3The company completed the acquisitions of Stoller and Symborg in March 2023, integrating them into the Crop Protection segment to enhance its biologicals offerings.
4Operating EBITDA for Q3 2023 was $18 million, a decrease from $96 million in Q3 2022, largely due to lower volumes and higher input costs.
5Year-to-date Operating EBITDA improved to $2,995 million from $2,854 million in the prior year, driven by price execution and cost savings.
6Corteva returned approximately $910 million to shareholders through share repurchases and dividends in the first nine months of 2023.
7A new plan to optimize the Crop Protection network was announced, expecting aggregate pre-tax charges of $410 million to $460 million.

Corteva, Inc. Quarterly Report for Q3 Ended Sep 30, 2023

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions